TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

You Are Here: Home  »  Research Funding  »  Small Business  » 

Skip secondary menu

Small Business Funding Opportunities


Funding Opportunities

The NINDS accepts a broad range of small business applications that are significant, innovative, and relevant to its mission. Small businesses are invited to apply for NINDS funding through the Omnibus Solicitations (PA-16-302 for SBIR; PA-16-303 for STTR) and the Direct to Phase II Solicitation (PAR-14-088).  The majority of our applications come through this general announcements. In addition, program staff will also solicit applications in specific program areas. Some specific program announcements include:

   Program Announcements

       Translational Programs for Therapeutics

        Small Molecules:

  • PAR-14-292: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)

        Devices:

  • PAR-14-296: NINDS CREATE Devices: Translational and Clinical Studies on the Path to 510(k) (U44)
  • PAR-14-299: NINDS CREATE Devices: Translational and Early Feasibility Studies on the Path to Pre-Market Approval (PMA) or Humanitarian Device Exemption (HDE) (U44)
  • PAR-14-300: NINDS CREATE Devices: Translational and Clinical Studies to Inform Final Device Design (U44)

        Biologics and Biotechnology Products:

  • PAR-14-289: NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)
  • PAR-14-287: NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)

        Clinical Trials

  • PAR-15-277/PAR-15-278: NINDS Exploratory Clinical Trials for Small Business (R44/R42)
  • PAR-14-265: NINDS Direct Phase II SBIR Grants to Support Exploratory Clinical Trials (R44)
  • PAR-15-194: NeuroNEXT Small Business Innovation in Clinical Trials Direct to Phase II (U44)
  • PAR-14-252: StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44)

        Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative

  • PAR-15-121: BRAIN Initiative: Optimization of Novel Tools and Technologies for Neuroscience Research (SBIR) (Direct to Phase II R44)
  • PAR-15-091: BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (R43/R44)
  • PAR-15-090: BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (R41/R42)

        Other Announcements

  • PA-14-154/PA-14-157: Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (SBIR/STTR)
  • PA-15-322/PA-15-321: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)

        Renewal Awards (Phase IIB)

  • PAR-14-209: NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44)
  • PAR-14-208: NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Exploratory Clinical Trials and Clinical Research (R44)

        Commercialization Assistance

  • PAR-16-026: SBIR/STTR Commercialization Readiness Pilot (CRP) Program: Technical Assistance (SB1)
  • PAR-16-027: SBIR/STTR Commercialization Readiness Pilot (CRP) Program: Technical Assistance and Late Stage Development (SB1)

    Notices

  • NOT-NS-16-010: Notice of the Increase in Budget Caps for Applications to PAR-14-287 "NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)"
  • NOT-NS-11-018: NINDS Policy for the Requirement of Authorization from the Food and Drug Administration (FDA) to use an Investigational Drug, Biologic Product or Device in a Clinical Trial Prior to Submission of an Application
  • NOT-OD-16-103: HHS issues PHS 2016-2 SBIR and STTR Omnibus Grant Funding Opportunity Announcements
  • NOT-OD-14-048: NIH Implements Option for Applicants to Switch between the SBIR/STTR programs and the SBIR Direct to Phase II pilot of the SBIR/STTR Reauthorization Act of 2011
  • NOT-OD-14-074: NIH Policy on Resubmission Applications
  • NOT-OD-15-038: HHS Changes Standard Due Dates for SBIR/STTR Grant Applications
  • NOT-OD-15-089: Racial and Ethnic Categories and Definitions for NIH Diversity Programs and for Other Reporting Purposes
  • NOT-OD-15-102: Consideration of Sex as a Biological Variable in NIH-funded Research
  • NOT-OD-15-103: Enhancing Reproducibility through Rigor and Transparency

    More details about these opportunities can be found in the NIH Guide for Grants and Contracts.

Last Modified June 17, 2016